Please login to the form below

Not currently logged in
Email:
Password:

Polyphor appoints new chief medical and development officer

Dr Debra Baker joins the firm from Novartis

Polyphor has appointed Debra Baker as its new chief medical and development officer (CMDO) in a role that focuses on clinical strategy and drug development.

Dr Baker arrives at Polyphor from Novartis, where she held several positions including global head of medical affairs, development head for infectious diseases, transplants and immunology, and global head of clinical operations and services.

She said: “it is an exciting time to join Polyphor and I am very eager to share my experience in drug development in its mission to help patients.”

Giacomo Di Nepi, CEO at Polyphor, added: “I am very happy Debra joins Polyphor. I had the opportunity of working with her at Novartis and really appreciated her leadership, drive and capabilities. Her expertise is immediately applicable to her new role as CMDO of Polyphor and to our clinical programmes,”

Dr Baker succeeds Leon Hootftman, who leaves Polyphor to take a new position.

17th March 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

The new pharma marketing playbook
Learn about the 5 areas that must be in your pharma marketing playbook...
Pharma needs to evolve from customer-centricity to stakeholder-centricity
Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
5 health behavioural factors to incorporate in your marketing
Achieve real health behaviour change by including these elements in your pharmaceutical marketing....

Infographics